White Paper on Tier-Based Testing for the Effects of Proteinaceous Insecticidal Plant-Incorporated Protectants

The purpose of this paper is to summarize scientific and regulatory information on nontarget invertebrate testing and evaluation of new products expressing insecticidal proteins in an ecological risk assessment. The information included provides a general discussion for conducting non-target invertebrate ecological risk assessments for crops expressing insecticidal proteins.

Spotlight

Yashraj Biotechnology Ltd

Yashraj Biotechnology Limited (YBL) is a part of the “YASHRAJ GROUP” having diversified interests in finance, construction, agriculture, chemicals and biotechnology. YBL was established in 1999 with a mission to achieve excellence in biotechnology and utilize its power for the good of humanity.

OTHER WHITEPAPERS
news image

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

Read More
news image

DIGITAL BIOTECH IS MISSION-CRITICAL TO MODERNA

whitePaper | May 20, 2022

We are living in a unique time in which the world is changing faster than ever. This largely is due to an influx and infusion of digital technologies that are reinventing and reimagining businesses across nearly every sector, and dramatically shifting societal and economic interactions. While the life science industry has, to some extent, adopted various digital technologies, it has not had a significant digital transformation in how it does business.

Read More
news image

Small Molecule Apis Made with Compelling Science

whitePaper | July 17, 2023

As your API demand grows, we grow with you. While we can manufacture volumes in metric tons, we can also go small. If you have a chemistry-based compound and need smaller batches for clinical or commercial use, we can offer the quantities you need at our cGMP small-scale/pilot facilities until you’re ready for full-scale manufacturing.

Read More
news image

6 Strategies to Stimulate Patient Engagementin Rehab Therapy

whitePaper | August 25, 2022

Patient engagement has become a measure of healthcare analytics that many in rehab therapy have sought to quantify.

Read More
news image

Liposomal and Nanoparticle Technology at Pfizer Melbourne

whitePaper | November 22, 2022

Specializing in oncology, anti-infective and complex formulations, Pfizer Melbourne provides end-to-end services from development through to commercial manufacture of sterile dosage forms.

Read More
news image

Accurate and reliable cell counting using holographic microscopy and machine learning algorithms

whitePaper | August 11, 2022

Reliable and accurate cell counts are crucial for many different purposes such as the maintenance of cell cultures in biological research or in-process controls in industrial bioprocessing.

Read More

Spotlight

Yashraj Biotechnology Ltd

Yashraj Biotechnology Limited (YBL) is a part of the “YASHRAJ GROUP” having diversified interests in finance, construction, agriculture, chemicals and biotechnology. YBL was established in 1999 with a mission to achieve excellence in biotechnology and utilize its power for the good of humanity.

Events